NCT06538181
- Conditions
- E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic Syndrome, VEXAS, VEXAS syndrome, +1 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Clinical trial condition
VEXAS
Explore clinical trials studying VEXAS. Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
VEXAS trial results
NCT06657846
- Conditions
- VEXAS, VEXAS syndrome
- Locations
-
- Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica Ancona, Italy
- Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia Bergamo, Italy
- Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia Bologna, Italy
- Asst Degli Spedali Civili Di Brescia - Uo Ematologia Brescia, Italy
Active, not recruiting
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
NCT06782373
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +7 more
- Locations
-
- Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic - Rochester Rochester, Minnesota, United States
- NYU Langone Health New York, United States
Completed
DECIPHERING AND TARGETING VEXAS
NCT07746986
- Conditions
- Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, MI, Italy